Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win ...

The first major global review of bird flu in cats reveals an emerging threat of a potential human pandemic. Spring is here, ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a ...

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...

Our fight against infectious diseases depends on strong intellectual property rights. Bird flu has swept across the United ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...

Bird flu is continuing to spread in animals across the United States more than a year after the first human case was detected ...

The award from the Biomedical Advanced Research and Development Authority (BARDA) will be used to accelerate the development of pandemic flu vaccines, according to Moderna, and specifically ...

Moderna is currently in the very early stages of testing a bird flu vaccine using the same mRNA technology that allowed for rapid development and rollout of COVID-19 vaccines. The funds from the ...